Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Novacyt S.a. LSE:NCYT London Ordinary Share FR0010397232 EUR1/15TH (CDI)
  Price Change % Change Share Price Shares Traded Last Trade
  -10.00 -3.17% 305.00 838,411 16:27:39
Bid Price Offer Price High Price Low Price Open Price
300.00 310.00 315.00 302.50 305.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 13.08 -3.91 -14.00 206
Last Trade Time Trade Type Trade Size Trade Price Currency
17:11:38 O 100,000 310.653 GBX

Novacyt (NCYT) Latest News

More Novacyt News
Novacyt Takeover Rumours

Novacyt (NCYT) Discussions and Chat

Novacyt Forums and Chat

Date Time Title Posts
28/5/202017:41COVID-1923,967
28/5/202000:00CV and The Deep State40
21/5/202010:26Novacyt SA shares soar on Coronavirus test kit.607
19/5/202001:31Coranavirus2,302
02/5/202012:18coronavirusTransmission facts vs fiction344

Add a New Thread

Novacyt (NCYT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:15:00310.65100,000310,653.00O
16:11:38305.004,90014,945.00O
15:34:03302.0010,00030,200.00O
15:30:03306.594851,486.98O
15:29:45307.002,6037,991.21O
View all Novacyt trades in real-time

Novacyt (NCYT) Top Chat Posts

DateSubject
28/5/2020
09:20
Novacyt Daily Update: Novacyt S.a. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker NCYT. The last closing price for Novacyt was 315p.
Novacyt S.a. has a 4 week average price of 292.50p and a 12 week average price of 82.50p.
The 1 year high share price is 517.50p while the 1 year low share price is currently 4.50p.
There are currently 67,673,567 shares in issue and the average daily traded volume is 816,351 shares. The market capitalisation of Novacyt S.a. is £206,404,379.35.
26/5/2020
09:44
bunz3: nice change to see how strong in France today thinking is this the start of a good move back up for share price to see this buying again in France be nice if share price moves back up £5 again or over if good news is released more people likely becoming aware of money ncyt now bringing in from manufacturing and sales watching to see when next rns is released
20/5/2020
12:51
bunz3: bountyhunter ,that's maybe reason why the posts hoping June might see ncyt share price move up
17/5/2020
06:32
1hatetrader: NCYT Targets Six months: 617.87 One year: 721.67 https://twitter.com/smallcappick/status/1261751390965305344 #Novacyt (ALNOV.FP) #NCYT 3.455 -0.435 (-11.18%) 05/15/20 [Euronext FR] BARCHART OPINION for Fri, May 15th, 2020 Overall Average: 80% BUY https://twitter.com/smallcappick/status/1261746761833447425 "The UK Gov has now announced that all staff and residents in English care homes will be tested for the virus by early JUNE" Coincidence #NCYT have found capacity for 10m #COVID19 tests in June? Even referenced care home testing in their last RNS 👀👇 https://twitter.com/smallcappick/status/1261589570048659456 healthcare companies that have had meteoritic share price rises, such as #NCYT https://twitter.com/smallcappick/status/1261586068085882880 Novacyt (LSE:#NCYT) has soared by 423% on the back of its Covid-19 test, which has certainly helped to boost its cash pile, which reached €9.2 million at the end of April https://twitter.com/smallcappick/status/1261584253634166784 Novacyt shares take a breather UK Investor Magazine https://twitter.com/smallcappick/status/1261544755428765698 NCYT Landmark Partnership & Refinancing Plans Unveiled by 2 LSE Stocks: #Novacyt SA & Spire Healthcare Group PLC https://twitter.com/smallcappick/status/1261544495528714240
14/5/2020
17:19
bunz3: third red dot thought was another rns the sales update people were expecting today also update on The development of a new "direct-to-PCR" extraction method, Exsig™ Free, used prior to running the Company's COVID-19 test The Directors believe this innovation should facilitate an increase in testing capacity for COVID-19, removing a current bottleneck in sample processing for laboratories. Development is progressing well and Novacyt is on track to launch this new extraction technology in May 2020. The Company continues to increase its sales level into the US market and is evaluating potential options to further expand its presence in this important market. so much news due this month if rns tomorrow afternoon or soon then might how much this share price can move up again also good to see how many good buys after 4pm don't tnink might be to long until share price might be back up again some see lower share prices an opportunity to top up with manufacturing going up to 10 million tests per month in june
10/5/2020
15:20
pwhite73: timeforchange1 - "I see a disaster arriving before the end of June." Initially I thought you were talking about the NCYT share price. But I can see you are talking about the end of the world or at least the UK. Well Covid-19 takes about three weeks from infection to kill in the worst case scenarios. Not enough are infected today to lend any credibility to your apocalypse prediction.
27/4/2020
03:08
bunz3: IF MORE NEWS SOON NOT GOOD FOR THEM THAT THEY WERE CAUGHT OUT LAST WHEN SOME OF THEM SOLD HOPING TO BUY BACK IM AT LOWER SHARE PRICE THEY SHOULD HAVE READ THIS RNS 30TH MARCH Sales and regulatory update As of 27 March, Primerdesign has sold and received orders for over £17.8 million (€19.6 million) of its CE-Mark and research use only (RUO) COVID-19 tests. The rate of demand for the test continues to increase, and on 27 March, Primerdesign received its largest single order to date of £1.4 million (€1.5 million) from a new customer in India following emergency use approval of the test on 26 March 2020. Novacyt is now selling its COVID-19 test to more than 80 countries and the Middle-East is becoming the strongest selling region, with orders of £1.6m (€1.8m) received in less than two weeks. The Company expects to sign further distribution partnerships during the next few weeks in this region and also expects to update on its progress in the US market following Emergency Use Authorization granted by the US Food and Drug Administration announced on 23 March 2020. Novacyt continues to work with a growing number of hospitals in the UK and is now supplying more than 21 hospitals across the country. The Company also reports that its COVID-19 test is now being used by the Health Service Executive in Ireland and orders for £1.1 million (€1.2 million) tests have been received. THEY SHOULD HAVE LOOKED AT THE DATE OF THE RNS I SUSPECT SOME OF THE MANY BUYERS INCLUDING MYSELF LOOKED AT THE DATE AND AFTER THE NEWS THAT NCYT MANUFACTURING 4 MILLION TESTS PER MONTH SO MUCH MONEY WELL DONE NCYT HOW MANY PEOPLE READ THE DATE OF THE RNS MABY I WOULD THINK WAS SO SURPRISED TO SEE THE DAYTRADERS SELLING TRYING TO GET A LOWER BUY IN PRICE THIS CLOSE TO THIS DATE THAT WAS WHY I BOUGHT MORE TO BE HOLDING IF GOOD NEWS THIS WEEK MIGHT NOT BE LONG UNTIL MY £10 TARGET SHARE PRICE WITH THE PROGRESS AT NCYT DAY TRADERS HOW CAN BE WRONG SO OFTEN FROM OVER A £1 GETTING IT WRONG IF THEY HAD BOUFGHT IN AND HELD HOW MUCH MONEY WOULD THEY HAVE MADE ALWAYS IMPORTANT DO ONE OWN RESEARCH SO MANY GOOD RNS TO HELP WITH RESEARCH AT NCYT THAT ANOTHER REASON WHY I LIKE THIS SHARE
27/4/2020
02:01
bunz3: THEY SHOULD HAVE LOOKED AT THE DATE OF THE RNS I SUSPECT SOME OF THE MANY BUYERS INCLUDING MYSELF LOOKED AT THE DATE AND AFTER THE NEWS THAT NCYT MANUFACTURING 4 MILLION TESTS PER MONTH SO MUCH MONEY WELL DONE NCYT HOW MANY PEOPLE READ THE DATE OF THE RNS MABY I WOULD THINK WAS SO SURPRISED TO SEE THE DAYTRADERS SELLING TRYING TO GET A LOWER BUY IN PRICE THIS CLOSE TO THIS DATE THAT WAS WHY I BOUGHT MORE TO BE HOLDING IF GOOD NEWS THIS WEEK MIGHT NOT BE LONG UNTIL MY £10 TARGET SHARE PRICE WITH THE PROGRESS AT NCYT DAY TRADERS HOW CAN BE WRONG SO OFTEN FROM OVER A £1 GETTING IT WRONG IF THEY HAD BOUFGHT IN AND HELD HOW MUCH MONEY WOULD THEY HAVE MADE ALWAYS IMPORTANT DO ONE OWN RESEARCH SO MANY GOOD RNS TO HELP WITH RESEARCH AT NCYT THAT ANOTHER REASON WHY I LIKE THIS SHARE
27/4/2020
01:56
bunz3: Sales and regulatory update As of 27 March, Primerdesign has sold and received orders for over £17.8 million (€19.6 million) of its CE-Mark and research use only (RUO) COVID-19 tests. The rate of demand for the test continues to increase, and on 27 March, Primerdesign received its largest single order to date of £1.4 million (€1.5 million) from a new customer in India following emergency use approval of the test on 26 March 2020. Novacyt is now selling its COVID-19 test to more than 80 countries and the Middle-East is becoming the strongest selling region, with orders of £1.6m (€1.8m) received in less than two weeks. The Company expects to sign further distribution partnerships during the next few weeks in this region and also expects to update on its progress in the US market following Emergency Use Authorization granted by the US Food and Drug Administration announced on 23 March 2020. Novacyt continues to work with a growing number of hospitals in the UK and is now supplying more than 21 hospitals across the country. The Company also reports that its COVID-19 test is now being used by the Health Service Executive in Ireland and orders for £1.1 million (€1.2 million) tests have been received. THEY SHOULD HAVE LOOKED AT THE DATE OF THE RNS I SUSPECT SOME OF THE MANY BUYERS INCLUDING MYSELF LOOKED AT THE DATE AND AFTER THE NEWS THAT NCYT MANUFACTURING 4 MILLION TESTS PER MONTH SO MUCH MONEY WELL DONE NCYT HOW MANY PEOPLE READ THE DATE OF THE RNS MABY I WOULD THINK WAS SO SURPRISED TO SEE THE DAYTRADERS SELLING TRYING TO GET A LOWER BUY IN PRICE THIS CLOSE TO THIS DATE THAT WAS WHY I BOUGHT MORE TO BE HOLDING IF GOOD NEWS THIS WEEK MIGHT NOT BE LONG UNTIL MY £10 TARGET SHARE PRICE WITH THE PROGRESS AT NCYT DAY TRADERS HOW CAN BE WRONG SO OFTEN FROM OVER A £1 GETTING IT WRONG IF THEY HAD BOUFGHT IN AND HELD HOW MUCH MONEY WOULD THEY HAVE MADE ALWAYS IMPORTANT DO ONE OWN RESEARCH SO MANY GOOD RNS TO HELP WITH RESEARCH AT NCYT THAT ANOTHER REASON WHY I LIKE THIS SHARE
27/4/2020
00:49
bunz3: DAY TRADESARE THEY GETTING ANNOYED NOT GOOD FOR THEM THAT THEY WERE CAUGHT OUT LAST WHEN SOME OF THEM SOLD HOPING TO BUY BACK IM AT LOWER SHARE PRICE THEY SHOULD HAVE READ THIS RNS 30TH MARCH Sales and regulatory update As of 27 March, Primerdesign has sold and received orders for over £17.8 million (€19.6 million) of its CE-Mark and research use only (RUO) COVID-19 tests. The rate of demand for the test continues to increase, and on 27 March, Primerdesign received its largest single order to date of £1.4 million (€1.5 million) from a new customer in India following emergency use approval of the test on 26 March 2020. Novacyt is now selling its COVID-19 test to more than 80 countries and the Middle-East is becoming the strongest selling region, with orders of £1.6m (€1.8m) received in less than two weeks. The Company expects to sign further distribution partnerships during the next few weeks in this region and also expects to update on its progress in the US market following Emergency Use Authorization granted by the US Food and Drug Administration announced on 23 March 2020. Novacyt continues to work with a growing number of hospitals in the UK and is now supplying more than 21 hospitals across the country. The Company also reports that its COVID-19 test is now being used by the Health Service Executive in Ireland and orders for £1.1 million (€1.2 million) tests have been received. THEY SHOULD HAVE LOOKED AT THE DATE OF THE RNS I SUSPECT SOME OF THE MANY BUYERS INCLUDING MYSELF LOOKED AT THE DATE AND AFTER THE NEWS THAT NCYT MANUFACTURING 4 MILLION TESTS PER MONTH SO MUCH MONEY WELL DONE NCYT HOW MANY PEOPLE READ THE DATE OF THE RNS MABY I WOULD THINK WAS SO SURPRISED TO SEE THE DAYTRADERS SELLING TRYING TO GET A LOWER BUY IN PRICE THIS CLOSE TO THIS DATE THAT WAS WHY I BOUGHT MORE TO BE HOLDING IF GOOD NEWS THIS WEEK MIGHT NOT BE LONG UNTIL MY £10 TARGET SHARE PRICE WITH THE PROGRESS AT NCYT DAY TRADERS HOW CAN BE WRONG SO OFTEN FROM OVER A £1 GETTING IT WRONG IF THEY HAD BOUFGHT IN AND HELD HOW MUCH MONEY WOULD THEY HAVE MADE ALWAYS IMPORTANT DO ONE OWN RESEARCH SO MANY GOOD RNS TO HELP WITH RESEARCH AT NCYT THAT ANOTHER REASON WHY I LIKE THIS SHARE
27/4/2020
00:13
bunz3: not good for the day traders from when share was over one pound try to deramp have most people at ncyt listend to them them don't think so looking at share price looking at number of buys last week even no don't don't think so have people done their own research read rns , even though buyers not listening to derampers /day traders they have given up even spending their time day and night ,weekends /day and night they trying so hard YET THEY FAILING so good of progress at ncyt so good of rns released at ncyt now that ncyt now manufacturing 4 MILLION COVID 19 TESTING KITS PER MONTH more buyers loading waiting for even more good rns will the next number of weeks see the share price start to move up TO A SHARE PRICE TO MATCH THE PROGRESS BY NCYT
Novacyt share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
NCYT
Novacyt
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200528 16:52:19